Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
NCT Number: NCT07522593
The goal of this clinical trial is to learn if Baduanjin exercise could be adopted by breast cancer survivors and improve their upper limb dysfunction. The main questions it aims to answer are:
* Does Baduanjin exercise improve upper limb dysfunction among breast cancer survivors? * What problems or adverse events do participants have if they adopt Baduanjin exercise to improve upper limb dysfunction?
Participants will:
* Adopt Baduanjin exercise following an evidence-based intervention protocol * Report their exercise frequency, length, and unexpected symptoms * Receive three times assessment and follow-up every week
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Zunyi, Guizhou, China
To evaluate the feasibility, acceptability, and preliminary effects of Baduanjin exercise on upper limb dysfunction (ULD), shoulder range of motion (ROM), pain, sleep quality, depression and anxiety, and quality of life (QoL) in breast cancer survivors. The objectives of this study are to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Baduanjin exercise is a low-to-moderate-intensity aerobic mind-body exercise that integrates movement (physical postures), meditation (focused attention), and controlled breathing. When practicing it, people stand in a position and perform eight movements, including 1) Two Hands Hold up the Heavens; 2) drawing the bow to shoot the eagle; 3)separate heaven and earth, 4)wise owl gazes backward or looking back, 5)sway the head and shake the tail, 6)two hands hold the keen to strengthen the kidneys and waist, 7) clench the fists and glare fiercely; 8) bouncing on the toes seven times.
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
The Disability of Arm, Shoulder, and Hand (DASH) (Chinese version) will assess upper limb dysfunction. The DASH has 30 items, and 5-Likert scale was used to demonstrate the disability of the upper limb (1=not at all, 2= slightly, 3= moderately, 4= quite a bit, 5= extremely), and DASH symptom score = [(sum of n response)/n-1] *25 (n is the number of completed responses)(Hudak et al., 1996). A higher score indicates a greater disability. At least 27 items must be completed for each questionnaire, or it will not be able to calculate a score.
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
The shoulder ROM includes flexion, extension, abduction, adduction, and internal and external rotation. A digital goniometer is a precision instrument commonly used to measure shoulder ROM in clinical settings. each movement will be measured and recorded once per assessment to minimize fatigue and prevent artificially increased ROM due to repeated measurements
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
The brief pain inventory (BPI) will be employed to measure pain among BCSs, which is a self-administered measure that can rapidly assess the intensity of pain and the impact of pain on daily function.
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
The Pittsburgh Sleep Quality Index (PSQI) (Chinese version) was adopted to evaluate sleep quality in the project. It was developed in 1989, with 19 items in seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction (Buysse et al., 1989). Each component score ranges from 0 (no difficulty) to 3 (severe difficulty), and the global score ranges from 0 to 21 points; a higher score indicates a worse sleep quality (Buysse et al., 1989).
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
The Hospital Anxiety and Depression Scale (HADS) was selected to assess the participants' depression and anxiety. HADS was developed in 1983 with 14 items, 7 items measuring cognitive and emotional aspects of depression, intermingled with 7 items that focus on cognitive and emotional aspects of anxiety(Zigmond & Snaith, 1983). Each item is scored from 0 to 3, resulting in a total subscale score ranging from 0 to 21. Higher scores indicate greater levels of depression or anxiety(Zigmond & Snaith, 1983)
Time frame: At enrollment, at the end of the intervention, and eight weeks after the intervention completion
FACT-B+4 will be used to assess the QoL among breast cancer survivors with upper limb dysfunction. FACT-B has 37 items, including 7 items for physical well-being, 7 items for social/family well-being, 6 items for emotional well-being, 7 items for functional well-being, and 10 additional items specific to breast cancer concerns(Brady et al., 1997). The FACT-B+4 is an extended version of the original one, and the "+4" refers to four additional items specifically designed to assess arm morbidity in BCSs(Coster et al., 2001). Each item of the FACT-B+4 is rated on a 5-point Likert scale from 0 (not at all) to 4 (very much), and the total score range is 0-168 (Some items are reverse scored). A higher score indicates a better QoL.
Contact information is provided by the study sponsor or research team.
University of Southern Queensland
Other
Feasibility and Preliminary Evaluation of an Evidence-based Baduanjin Exercise Program for Upper Limb Dysfunction in Breast Cancer Survivors: A Pilot Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06865755
Behavior, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
San Diego, California, United States
View Trial DetailsNCT07122492
Breast Cancer Survivor, Fear of Cancer Recurrence
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06994351
Anxiety Disorders, Anxiety and Depression
Beijing, China
View Trial DetailsNCT06952270
Behavior, Breast Cancer
Pontevedra, Spain
View Trial Details